Literature DB >> 1330388

Cytokine receptors: structure and signal transduction.

B M Foxwell1, K Barrett, M Feldmann.   

Abstract

In the past 2-3 years, a number of cytokine receptors have been partly characterized and the cDNAs for the ligand binding chains cloned. This has revealed that cytokine receptors are complex. Many are known to be multichain receptors (e.g. IL-2) and since their mechanism of signal transduction is not obvious, it is likely that other proteins yet to be defined take part in the signalling process. The cloning of the receptor ligand binding chain has revealed that (unlike cytokines), there are major families of receptors. Some are members of the Ig supergene family (e.g. IL-1 receptor), others are members of the nerve growth factor receptor family (e.g. TNF), but the majority are members of the haematopoietic growth factor family (e.g. IL-3, GM-CSF). Yet other cytokine receptors do not belong to a family, e.g. IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330388      PMCID: PMC1554615          DOI: 10.1111/j.1365-2249.1992.tb07922.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  95 in total

1.  Chimeric interferon-gamma receptors demonstrate that an accessory factor required for activity interacts with the extracellular domain.

Authors:  Y Hibino; C S Kumar; T M Mariano; D H Lai; S Pestka
Journal:  J Biol Chem       Date:  1992-02-25       Impact factor: 5.157

2.  The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor.

Authors:  D P Gearing; M R Comeau; D J Friend; S D Gimpel; C J Thut; J McGourty; K K Brasher; J A King; S Gillis; B Mosley
Journal:  Science       Date:  1992-03-13       Impact factor: 47.728

3.  An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: a cytokine receptor superfamily oncogene.

Authors:  G D Longmore; H F Lodish
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

4.  Mitogenic signalling pathway of tumour necrosis factor involves the rapid tyrosine phosphorylation of 41,000-Mr and 43,000-Mr cytosol proteins.

Authors:  M Kohno; N Nishizawa; M Tsujimoto; H Nomoto
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

5.  Cloning and expression of a gene encoding an interleukin 3 receptor-like protein: identification of another member of the cytokine receptor gene family.

Authors:  D M Gorman; N Itoh; T Kitamura; J Schreurs; S Yonehara; I Yahara; K Arai; A Miyajima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

6.  Purification and characterization of the receptor for murine granulocyte colony-stimulating factor.

Authors:  R Fukunaga; E Ishizaka-Ikeda; S Nagata
Journal:  J Biol Chem       Date:  1990-08-15       Impact factor: 5.157

7.  Engagement of interleukin-7 receptor stimulates tyrosine phosphorylation, phosphoinositide turnover, and clonal proliferation of human T-lineage acute lymphoblastic leukemia cells.

Authors:  I Dibirdik; M C Langlie; J A Ledbetter; L Tuel-Ahlgren; V Obuz; K G Waddick; K Gajl-Peczalska; G L Schieven; F M Uckun
Journal:  Blood       Date:  1991-08-01       Impact factor: 22.113

8.  The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family.

Authors:  D Camerini; G Walz; W A Loenen; J Borst; B Seed
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

9.  IL-7 receptor mediates tyrosine phosphorylation but does not activate the phosphatidylinositol-phospholipase C-gamma 1 pathway.

Authors:  C M Roifman; G X Wang; M Freedman; Z Q Pan
Journal:  J Immunol       Date:  1992-02-15       Impact factor: 5.422

10.  Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor.

Authors:  C Brakebusch; Y Nophar; O Kemper; H Engelmann; D Wallach
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more
  6 in total

1.  A phage-displayed mimotope inhibits tumour necrosis factor-alpha-induced cytotoxicity more effectively than the free mimotope.

Authors:  C L Chirinos-Rojas; M W Steward; C D Partidos
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

2.  A form of circulating interleukin-6 receptor component soluble gp130 as a potential interleukin-6 inhibitor in inflammatory bowel disease.

Authors:  K Mitsuyama; N Tomiyasu; A Suzuki; K Takaki; H Takedatsu; J Masuda; H Yamasaki; S Matsumoto; O Tsuruta; A Toyonaga; M Sata
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

Review 3.  Hepatocyte and immune system: acute phase reaction as a contribution to early defence mechanisms.

Authors:  C Trautwein; K Böker; M P Manns
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

4.  Cytokines and cytokine receptors: from cloning to the clinic. Keystone symposium on molecular and cellular biology (1993).

Authors:  F M Brennan
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

Review 5.  The erythropoietin receptor: molecular structure and hematopoietic signaling pathways.

Authors:  Stephanie S Watowich
Journal:  J Investig Med       Date:  2011-10       Impact factor: 2.895

6.  Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6.

Authors:  K Mitsuyama; A Toyonaga; E Sasaki; O Ishida; H Ikeda; O Tsuruta; K Harada; H Tateishi; T Nishiyama; K Tanikawa
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.